10 SPACs Trading Below $10 with Proven Serial SPAC Sponsors

by | Dec 30, 2021

A big part of the current SPAC trade is the “risklesss” yield play supported by the ability to redeem at $10 in advance of the deal vote (specifically prior to ex-redemption). There is plenty of opportunity for those looking to head into 2022 with a basket full of discounted SPACs.

The list below shows 10 of discounted SPACs that are trading below $10 AND have SPAC sponsors with positive deSPAC returns as of December 29. SPAC investors will recognize M. Klein and Company, dMY Technology, Fortress, and True Wind Capital as having some of the best performing SPACs / deSPACs out there.

We’ve added in details on each sponsor — how many SPACs they’ve done, how many active, and deSPAC returns — so you can have a sense of the team behind the deal. You can also click through for additional details on the team behind the deal.

ALCC – AltC Acquisition Corp.

Sponsor: M. Klein and Company
Target: Technology

Prices
Common $ 9.77

Sponsor Track Record
Total SPACs: 8
Pre-IPO: 0
Pre-Deal: 4
Announced: 0
deSPACs: 4

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 34.8%
Max: 151.3%
Min: -36.9%

ARYE – ARYA Sciences Acquisition Corp V

Sponsor: Perceptive Advisors
Target: healthcare or healthcare related industries

Prices
Common $ 9.70

Sponsor Track Record
Total SPACs: 5
Pre-IPO: 0
Pre-Deal: 1
Announced: 1
deSPACs: 3

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 28.8%
Max: 113.6%
Min: -34.2%

TWCB – Bilander Acquisition Corp.

Sponsor: True Wind Capital
Target: Technology industry

Prices
Unit $ 10.05
Common $ 9.73

Sponsor Track Record
Total SPACs: 7
Pre-IPO: 3
Pre-Deal: 1
Announced: 0
deSPACs: 3

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 1.1%
Max: 22.8%
Min: -14.2%

CCV – Churchill Capital Corp V

Sponsor: M. Klein and Company
Target: None

Prices
Unit $ 10.18
Common $ 9.92

Sponsor Track Record
Total SPACs: 8
Pre-IPO: 0
Pre-Deal: 4
Announced: 0
deSPACs: 4

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 34.8%
Max: 151.3%
Min: -36.9%

CCVI – Churchill Capital Corp VI

Sponsor: M. Klein and Company
Target: General

Prices
Unit $ 10.00
Common $ 9.77

Sponsor Track Record
Total SPACs: 8
Pre-IPO: 0
Pre-Deal: 4
Announced: 0
deSPACs: 4

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 34.8%
Max: 151.3%
Min: -36.9%

CVII – Churchill Capital Corp VII

Sponsor: M. Klein and Company
Target: General

Prices
Unit $ 10.04
Common $ 9.83

Sponsor Track Record
Total SPACs: 8
Pre-IPO: 0
Pre-Deal: 4
Announced: 0
deSPACs: 4

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 34.8%
Max: 151.3%
Min: -36.9%

CPAA – Conyers Park III Acquisition Corp.

Sponsor: Centerview Capital
Target: consumer sector and consumer-related businesses

Prices
Unit $ 10.00
Common $ 9.75

Sponsor Track Record
Total SPACs: 3
Pre-IPO: 0
Pre-Deal: 1
Announced: 0
deSPACs: 2

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 9.8%
Max: 31.0%
Min: -11.4%

DMYS – dMY Technology Group, Inc. VI

Sponsor: dMY
Target: gaming, entertainment, education, e-commerce, dating and health and wellness

Prices
Unit $ 10.42
Common $ 9.81

Sponsor Track Record
Total SPACs: 5
Pre-IPO: 0
Pre-Deal: 1
Announced: 0
deSPACs: 4

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 8.8%
Max: 65.8%
Min: -40.2%

FCAX – Fortress Capital Acquisition Corp

Sponsor: Fortress
Target: Financial Services

Prices
Unit $ 9.92
Common $ 9.75

Sponsor Track Record
Total SPACs: 6
Pre-IPO: 0
Pre-Deal: 3
Announced: 0
deSPACs: 3

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 28.9%
Max: 144.9%
Min: -57.8%

FVT – Fortress Value Acquisition Corp. III

Sponsor: Fortress
Target: None

Prices
Unit $ 9.95
Common $ 9.77

Sponsor Track Record
Total SPACs: 6
Pre-IPO: 0
Pre-Deal: 3
Announced: 0
deSPACs: 3

Sponsor deSPAC Returns Since IPO (annualized)
Avg: 28.9%
Max: 144.9%
Min: -57.8%

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

SPAC Market Review – April 2022

The market is a mess right now. A hawkish Fed and even more cautious SEC are slowing deals….but may raise the bar for more quality SPACs down the line.

SPAC Market Review – March 2022

Despite increased scrutiny and apparent investor fatigue, deals are getting done and SPACs remain an attractive path to the public markets.

SPAC Research & Analysis

Alvotech Puts Iceland on the SPAC Map

Icelandic biopharma Alvotech deSPACs today. DHAC announces DA with VSee Lab. Deal termination for AKIC and visual effects company DNEG. A flurry of extension votes. And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

NYC Pension Funds Want Amazon Accountable for Human Capital

AMZN stock is performing, but are warehouse workers paying the price? We talk to Assistant NYC Comptroller Michael Garland on the NYC Pension Funds’ move to unseat two Amazon board members responsible for human capital management at the tech giant.

Boardroom Alpha Daily Read

Board blow-up at Redbox Entertainment. Mill Road Capital Pushing for a Sale of Big Lots. Happy Earth Day! A perfect time to tune into our latest ESG podcast.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.